DuPont reported higher earnings on improved margins even as sales figures were hurt by foreign currency headwinds as a planned merger with Dow Chemical Co moves forward.
Having a crisis communications plan in place to deal with allegations of financial impropriety is a must for a public company, as ChromaDex Corp recently learned to its chagrin.
The management team of Milk Specialities Global has partnered with a private equity firm to acquire the assets of the company, it was announced yesterday.
The management of Omega Protein Corporation has lost its defensive battle with Wynnefield Capital as the investment’s firm’s preferred board nominees were overwhelmingly elected by shareholders on Tuesday.
ProBiora Health, LLC, an entity owned by Ms. Christine L. Koski, has agreed to buy the consumer probiotic business of Oragenics, Inc. for $1.7 million in cash.
Investment experts and industry-leading entrepreneurs will provide insights and tips on how to improve the odds of successfully obtaining financing during the upcoming “Financing Your Consumer Products Company” seminar.
The Doctor’s Best brand of supplements has been sold to a major Chinese ingredient manufacturer, which is part of a trend in the industry, one observer said.
Another company has reported success with an acquisition in the dietary supplements ingredients space as Hawkins, Inc. reported strong earnings growth attributed in part to its purchase of Stauber.
A hangover from the negative publicity of the past year has stalled M&A and financing activity in dietary supplements, even as this activity booms in other categories of the health and wellness space, according to investment group Nutrition Capital...
In US basketball lingo they call it playing small ball. Frutarom, which supplies flavors, fragrances and dietary supplement ingredients, has grown to one of the world’s largest companies in the category by acquiring many of the smallest firms.
Canadian krill oil supplier Neptune Technologies and Bioressources is moving up the value chain by acquiring formulation service provider Biodroga for about $10.6 million (USD).
Hawkins Inc. has announced completion of its acquisition of Stauber Performance Ingredients in a cash for stock transaction valued at $157 million. It’s the second time Stauber has changed hands in recent years.
Marine Ingredients continues to build out its capabilities along the omega-3 value chain with its recent acquisition of a Florida-based softgel manufacturer.
